Specify a stock or a cryptocurrency in the search bar to get a summary
Biora Therapeutics Inc
BIORBiora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. Address: 4330 La Jolla Village Drive, San Diego, CA, United States, 92122
Analytics
WallStreet Target Price
97.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BIOR
Dividend Analytics BIOR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BIOR
Stock Valuation BIOR
Financials BIOR
Results | 2019 | Dynamics |